US09073Q3039 - ADR
SCINAI IMMUNOTHERAPEUTICS LT
NASDAQ:SCNI (6/28/2024, 7:25:47 PM)
After market: 2.76 -0.02 (-0.72%)2.78
-0.08 (-2.8%)
BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The firm's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
SCINAI IMMUNOTHERAPEUTICS LT
Jerusalem Biopark, 2Nd Floor, Hadassah Ein Kerem Campus
JERUSALEM
P: 97289302529
Employees: 33
Website: https://www.scinai.com/
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
Tuesday's session: top gainers and losers
AMC Networks stock is down on Monday after AMCX investors learned of a $125 million private offering of convertible senior notes.
Kaival Brands Innovations stock is down on Monday after shares of KAVL underwent a massive rally on Friday that sent it over 300% higher!
ENDRA Life Sciences stock is up on Monday with heavy trading of NDRA shares following a shareholder update from the company.
Scinai Immunotherapeutics stock is up on Monday with heavy trading of SCNI shares despite a lack of news from the company.
Here you can normally see the latest stock twits on SCNI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: